Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review

Atypical teratoid/rhabdoid tumours (AT/RTs) are rare central nervous system neoplasms that frequently occur in infants and children and have a very poor prognosis. In recent years, molecular analysis of AT/RTs has shown that biallelic inactivation of SMARCB1 (INI1, SNF5, BAF47) or SMARCA4 (BRG1) fre...

Full description

Bibliographic Details
Main Authors: Zhibin Li, Yubo Wang, Yuanhao Liu, Yining Jiang, Xuefei Han, Liyan Zhao, Yunqian Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1237572/full
_version_ 1797729021490888704
author Zhibin Li
Yubo Wang
Yuanhao Liu
Yining Jiang
Xuefei Han
Liyan Zhao
Yunqian Li
author_facet Zhibin Li
Yubo Wang
Yuanhao Liu
Yining Jiang
Xuefei Han
Liyan Zhao
Yunqian Li
author_sort Zhibin Li
collection DOAJ
description Atypical teratoid/rhabdoid tumours (AT/RTs) are rare central nervous system neoplasms that frequently occur in infants and children and have a very poor prognosis. In recent years, molecular analysis of AT/RTs has shown that biallelic inactivation of SMARCB1 (INI1, SNF5, BAF47) or SMARCA4 (BRG1) frequently occurs. Here, we present a case of basal ganglia AT/RT with SMARCB1 gene deficiency and CDK6 gene amplification in a 5-year-old child. A 5-year-old boy was hospitalized due to a 1-week history of frontal and parietal headache. Magnetic resonance imaging (MRI) demonstrated a 3 cm × 2 cm × 1.5 cm heterogeneous enhanced mass located at the right basal ganglia that partially protruded into the right lateral ventricle. The lesion was successfully resected under electrophysiological monitoring and neuronavigation. The postoperative pathological examination implied an AT/RT diagnosis, with loss of SMARCB1 protein, SMARCB1 gene deficiency and CDK6 gene amplification. Unfortunately, the patient died due to respiratory and circulatory failure at 5 weeks after the operation. To date, standard regimens have not yet been established due to the lack of large-scale prospective studies for AT/RT. The p16-RB signalling pathway should be considered as a potential target for AT/RT treatment modalities. Apart from traditional regimens, targeted therapies, especially CDK4/6 inhibitors, are likely a promising therapeutic option for AT/RT treatment.
first_indexed 2024-03-12T11:22:50Z
format Article
id doaj.art-4310f15b998742f18d1345d8aae6af94
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-03-12T11:22:50Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-4310f15b998742f18d1345d8aae6af942023-09-01T15:07:30ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-08-011110.3389/fped.2023.12375721237572Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature reviewZhibin Li0Yubo Wang1Yuanhao Liu2Yining Jiang3Xuefei Han4Liyan Zhao5Yunqian Li6Department of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaDepartment of Clinical Laboratory, Second Hospital of Jilin University, Changchun, ChinaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, ChinaAtypical teratoid/rhabdoid tumours (AT/RTs) are rare central nervous system neoplasms that frequently occur in infants and children and have a very poor prognosis. In recent years, molecular analysis of AT/RTs has shown that biallelic inactivation of SMARCB1 (INI1, SNF5, BAF47) or SMARCA4 (BRG1) frequently occurs. Here, we present a case of basal ganglia AT/RT with SMARCB1 gene deficiency and CDK6 gene amplification in a 5-year-old child. A 5-year-old boy was hospitalized due to a 1-week history of frontal and parietal headache. Magnetic resonance imaging (MRI) demonstrated a 3 cm × 2 cm × 1.5 cm heterogeneous enhanced mass located at the right basal ganglia that partially protruded into the right lateral ventricle. The lesion was successfully resected under electrophysiological monitoring and neuronavigation. The postoperative pathological examination implied an AT/RT diagnosis, with loss of SMARCB1 protein, SMARCB1 gene deficiency and CDK6 gene amplification. Unfortunately, the patient died due to respiratory and circulatory failure at 5 weeks after the operation. To date, standard regimens have not yet been established due to the lack of large-scale prospective studies for AT/RT. The p16-RB signalling pathway should be considered as a potential target for AT/RT treatment modalities. Apart from traditional regimens, targeted therapies, especially CDK4/6 inhibitors, are likely a promising therapeutic option for AT/RT treatment.https://www.frontiersin.org/articles/10.3389/fped.2023.1237572/fullatypical teratoid/rhabdoid tumourcase reportcentral nervous system neoplasmsCDK6treatmentCDK4/6 inhibitors
spellingShingle Zhibin Li
Yubo Wang
Yuanhao Liu
Yining Jiang
Xuefei Han
Liyan Zhao
Yunqian Li
Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
Frontiers in Pediatrics
atypical teratoid/rhabdoid tumour
case report
central nervous system neoplasms
CDK6
treatment
CDK4/6 inhibitors
title Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
title_full Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
title_fullStr Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
title_full_unstemmed Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
title_short Atypical teratoid/rhabdoid tumour with CDK6 amplification in a child: a case report and literature review
title_sort atypical teratoid rhabdoid tumour with cdk6 amplification in a child a case report and literature review
topic atypical teratoid/rhabdoid tumour
case report
central nervous system neoplasms
CDK6
treatment
CDK4/6 inhibitors
url https://www.frontiersin.org/articles/10.3389/fped.2023.1237572/full
work_keys_str_mv AT zhibinli atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT yubowang atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT yuanhaoliu atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT yiningjiang atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT xuefeihan atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT liyanzhao atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview
AT yunqianli atypicalteratoidrhabdoidtumourwithcdk6amplificationinachildacasereportandliteraturereview